These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36588724)

  • 61. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
    Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
    J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness.
    Dullaart RP; Perton F; Sluiter WJ; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4860-6. PubMed ID: 18782872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
    Awadallah S; Madkour M; Hamidi RA; Alwafa EA; Hattab M; Zakkour B; Al-Matroushi A; Ahmed E; Al-Kitbi M
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S543-S546. PubMed ID: 28416369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.
    Gebhard C; Rhainds D; He G; Rodés-Cabau J; Lavi S; Spence JD; Title L; Kouz S; L'Allier PL; Grégoire J; Ibrahim R; Cossette M; Guertin MC; Beanlands R; Rhéaume E; Tardif JC
    Atherosclerosis; 2018 Sep; 276():131-139. PubMed ID: 30059844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency.
    Fistrek Prlic M; Coric M; Calabresi L; Pavanello C; Mosca L; Cavallari U; Vukovic Brinar I; Karanovic S; Laganovic M; Jelakovic B
    Atheroscler Plus; 2022 Aug; 49():28-31. PubMed ID: 36644204
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Formation of pregnenolone- and dehydroepiandrosterone-fatty acid esters by lecithin-cholesterol acyltransferase in human plasma high density lipoproteins.
    Lavallée B; Provost PR; Belanger A
    Biochim Biophys Acta; 1996 Feb; 1299(3):306-12. PubMed ID: 8597585
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory effects of lipid oxidation on the activity of plasma lecithin-cholesterol acyltransferase.
    Kamiyama S; Yamato T; Furukawa Y
    Biosci Biotechnol Biochem; 1998 May; 62(5):941-6. PubMed ID: 9648224
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of ethanol on lecithin:cholesterol acyltransferase (LCAT) activity.
    Mulligan JJ; Cluette-Brown JE; Noring R; Igoe FD; Chong J; Hojnacki JL
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):181-202. PubMed ID: 3992006
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity.
    Bielicki JK; Forte TM; McCall MR
    J Lipid Res; 1996 May; 37(5):1012-21. PubMed ID: 8725153
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn).
    Klein HG; Lohse P; Duverger N; Albers JJ; Rader DJ; Zech LA; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1993 Jan; 34(1):49-58. PubMed ID: 8445342
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
    Zhao Y; Thorngate FE; Weisgraber KH; Williams DL; Parks JS
    Biochemistry; 2005 Jan; 44(3):1013-25. PubMed ID: 15654758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
    Tomimoto S; Tsujita M; Okazaki M; Usui S; Tada T; Fukutomi T; Ito S; Itoh M; Yokoyama S
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):394-400. PubMed ID: 11231919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FER(HDL)) and AIP [log(TG/HDL-C)] biomarkers: the butterfly effect?
    Dobiášová M
    Physiol Res; 2017 May; 66(2):193-203. PubMed ID: 28471688
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.